{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T14:00:06Z","timestamp":1790085606435,"version":"4.0.1"},"reference-count":23,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","nmcd-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Nutrition, Metabolism and Cardiovascular Diseases"],"published-print":{"date-parts":[[2026,6]]},"DOI":"10.1016\/j.numecd.2026.104621","type":"journal-article","created":{"date-parts":[[2026,2,10]],"date-time":"2026-02-10T16:43:36Z","timestamp":1770741816000},"page":"104621","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Pleiotropic cardiometabolic effects of the LDLR rs6511720\u00a0T allele: an evaluation of genetic risk across metabolic states"],"prefix":"10.1016","volume":"36","author":[{"given":"Danyel","family":"Chermon","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lydia","family":"Abu Samra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Noa","family":"Elkayam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5770-4277","authenticated-orcid":false,"given":"Ruth","family":"Birk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.numecd.2026.104621_bib1","doi-asserted-by":"crossref","first-page":"2459","DOI":"10.1093\/eurheartj\/ehx144","article-title":"Low-density lipoproteins cause atherosclerotic cardiovascular disease: evidence from genetic, epidemiologic, and clinical studies","volume":"38","author":"Ference","year":"2017","journal-title":"Eur Heart J"},{"key":"10.1016\/j.numecd.2026.104621_bib2","first-page":"669","article-title":"Familial hypercholesterolemia","volume":"14","author":"Pejic","year":"2014","journal-title":"Ochsner J"},{"key":"10.1016\/j.numecd.2026.104621_bib3","doi-asserted-by":"crossref","first-page":"914","DOI":"10.1136\/hrt.2006.112508","article-title":"Intensive statin therapy in acute coronary syndromes and stable coronary heart disease: a comparative meta\u2010analysis of randomised controlled trials","volume":"93","author":"Afilalo","year":"2007","journal-title":"Heart"},{"key":"10.1016\/j.numecd.2026.104621_bib4","doi-asserted-by":"crossref","first-page":"1500","DOI":"10.1056\/NEJMoa1500858","article-title":"Efficacy and safety of evolocumab in reducing lipids and cardiovascular events","volume":"372","author":"Sabatine","year":"2015","journal-title":"N Engl J Med"},{"key":"10.1016\/j.numecd.2026.104621_bib5","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1038\/nature09270","article-title":"Biological, clinical and population relevance of 95 loci for blood lipids","volume":"466","author":"Teslovich","year":"2010","journal-title":"Nature"},{"key":"10.1016\/j.numecd.2026.104621_bib6","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0167676","article-title":"Identification of the functional variant(s) that explain the low-density lipoprotein receptor (LDLR) GWAS SNP rs6511720 association with lower LDL-C and risk of CHD","volume":"11","author":"Fairoozy","year":"2016","journal-title":"PLoS One"},{"key":"10.1016\/j.numecd.2026.104621_bib7","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1001\/jama.2015.1206","article-title":"Association between familial hypercholesterolemia and prevalence of type 2 diabetes mellitus","volume":"313","author":"Besseling","year":"2015","journal-title":"JAMA"},{"key":"10.1016\/j.numecd.2026.104621_bib8","doi-asserted-by":"crossref","DOI":"10.1016\/j.atherosclerosis.2015.04.413","article-title":"Identification of the functional variant(s) behind the GWAS SNP for lower LDL-C and risk of CHD rs6511720","volume":"241","author":"Fairoozy","year":"2015","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.numecd.2026.104621_bib9","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1186\/1755-8794-7-17","article-title":"A genetic variant in the LDLR promoter is responsible for part of the LDL-cholesterol variability in primary hypercholesterolemia","volume":"7","author":"De Castro-Or\u00f3s","year":"2014","journal-title":"BMC Med Genom"},{"key":"10.1016\/j.numecd.2026.104621_bib10","doi-asserted-by":"crossref","first-page":"17","DOI":"10.3352\/jeehp.2021.18.17","article-title":"Sample size determination and power analysis using the G*Power software","volume":"18","author":"Becker","year":"2021","journal-title":"J Educ Eval Health Prof"},{"key":"10.1016\/j.numecd.2026.104621_bib11","series-title":"StatPearls [Internet]","article-title":"Hypercholesterolemia","author":"Ibrahim","year":"2025"},{"key":"10.1016\/j.numecd.2026.104621_bib12","unstructured":"Hubacek JA, Lanska V, Adamkova V. Sex-specific effect of the LDL-receptor rs6511720 polymorphism on plasma cholesterol levels. Results from the Czech post-MONICA study. Energy, Environment, Biology and Biomedicine. [Unpublished or in press]."},{"key":"10.1016\/j.numecd.2026.104621_bib13","doi-asserted-by":"crossref","first-page":"406","DOI":"10.3858\/emm.2009.41.6.046","article-title":"Sterol-independent repression of low density lipoprotein receptor promoter by peroxisome proliferator activated receptor \u03b3 coactivator-1\u03b1 (PGC-1\u03b1)","volume":"41","author":"Jeong","year":"2009","journal-title":"Exp Mol Med"},{"key":"10.1016\/j.numecd.2026.104621_bib14","doi-asserted-by":"crossref","first-page":"25","DOI":"10.3390\/jcdd11010025","article-title":"Effects of Serum Estradiol on Proprotein Convertase Subtilisin\/Kexin type 9 levels and lipid profiles in women undergoing in vitro fertilization","volume":"11","author":"Papanikolaou","year":"2024","journal-title":"J Cardiovasc Dev Dis"},{"key":"10.1016\/j.numecd.2026.104621_bib15","doi-asserted-by":"crossref","first-page":"1125","DOI":"10.1172\/JCI0215593","article-title":"SREBPs: activators of the complete program of cholesterol and fatty acid synthesis in the liver","volume":"109","author":"Horton","year":"2002","journal-title":"J Clin Investig"},{"key":"10.1016\/j.numecd.2026.104621_bib16","doi-asserted-by":"crossref","first-page":"1383","DOI":"10.1001\/jama.2016.14568","article-title":"Association between low-density lipoprotein cholesterol-lowering genetic variants and risk of type 2 diabetes: a meta-analysis","volume":"316","author":"Lotta","year":"2016","journal-title":"JAMA"},{"key":"10.1016\/j.numecd.2026.104621_bib17","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1016\/S0140-6736(14)61183-1","article-title":"HMG-coenzyme A reductase inhibition, type 2 diabetes, and bodyweight: evidence from genetic analysis and randomised trials","volume":"385","author":"Swerdlow","year":"2015","journal-title":"Lancet"},{"key":"10.1016\/j.numecd.2026.104621_bib18","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1111\/joim.12614","article-title":"Can LDL cholesterol be too low? Possible risks of extremely low levels","volume":"281","author":"Olsson","year":"2017","journal-title":"J Intern Med"},{"key":"10.1016\/j.numecd.2026.104621_bib19","doi-asserted-by":"crossref","first-page":"16904","DOI":"10.1074\/jbc.M010955200","article-title":"Cholesterol, a cell size-dependent signal that regulates glucose metabolism and gene expression in adipocytes","volume":"276","author":"Le Lay","year":"2001","journal-title":"J Biol Chem"},{"key":"10.1016\/j.numecd.2026.104621_bib20","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1373\/clinchem.2014.231365","article-title":"Refinement of variant selection for the LDL cholesterol genetic risk score in the diagnosis of the polygenic form of clinical familial hypercholesterolemia and replication in samples from 6 countries","volume":"61","author":"Futema","year":"2015","journal-title":"Clin Chem"},{"key":"10.1016\/j.numecd.2026.104621_bib21","first-page":"139","article-title":"Study of the effectiveness of statins in coronary heart disease after stentration in persons of the Uzbek population","volume":"9","author":"Urolovich","year":"2022","journal-title":"Eurasian Med Res Period"},{"key":"10.1016\/j.numecd.2026.104621_bib22","doi-asserted-by":"crossref","DOI":"10.15420\/ecr.2023.14","article-title":"Proprotein convertase Subtilisin\/Kexin type 9 inhibition: the big step forward in lipid control","volume":"18","author":"Rikhi","year":"2023","journal-title":"Eur Cardiol"},{"key":"10.1016\/j.numecd.2026.104621_bib23","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1186\/s12944-025-02502-z","article-title":"Causal relationship between drug target genes of LDL-cholesterol and coronary artery disease: drug target Mendelian randomization study","volume":"24","author":"Jee","year":"2025","journal-title":"Lipids Health Dis"}],"container-title":["Nutrition, Metabolism and Cardiovascular Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0939475326000839?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0939475326000839?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T13:04:45Z","timestamp":1790082285000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0939475326000839"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6]]},"references-count":23,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2026,6]]}},"alternative-id":["S0939475326000839"],"URL":"https:\/\/doi.org\/10.1016\/j.numecd.2026.104621","relation":{},"ISSN":["0939-4753"],"issn-type":[{"value":"0939-4753","type":"print"}],"subject":[],"published":{"date-parts":[[2026,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Pleiotropic cardiometabolic effects of the LDLR rs6511720\u00a0T allele: an evaluation of genetic risk across metabolic states","name":"articletitle","label":"Article Title"},{"value":"Nutrition, Metabolism and Cardiovascular Diseases","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.numecd.2026.104621","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Published by Elsevier B.V. on behalf of The Italian Diabetes Society, the Italian Society for the Study of Atherosclerosis, the Italian Society of Human Nutrition and the Department of Clinical Medicine and Surgery, Federico II University.","name":"copyright","label":"Copyright"}],"article-number":"104621"}}